|Bid||253.60 x 243000|
|Ask||253.70 x 260500|
|Day's Range||252.00 - 255.00|
|52 Week Range||218.30 - 273.00|
|PE Ratio (TTM)||22.08|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
When Pascal Soriot, chief executive of AstraZeneca, travelled to Chicago in 2014 to attend a prestigious annual gathering of cancer specialists, he could muster only a handful of innovative medicines with ...
Shares of NewLink Genetics Corp. plunged 31% in premarket trade Thursday, putting them on track to open at a more-than 5-year low, after the biopharmaceutical company said Genentech planned to return the ...
European stocks move a leg lower on Tuesday, as investors err on the side of caution ahead of potentially market-moving events later this week, including the U.K.’s general election and a European Central ...